Answers are grounded in this paper and cite their sources.
Understanding the extent to which alcohol consumption impacts subsequent health-related outcomes remains one of the most important and challenging topics in the field of alcohol research. Does heavy alcohol consumption play a causal role in the development of downstream health conditions like cardiovascular disease or type 2 diabetes? Is low-level drinking actively protective against these conditions? Historically, questions such as these stem from frequently observed nonlinear dose-response associations between alcohol consumption and risk of negative health conditions and consequences often following a J- or U-shaped curve (see Figure 1). These associations have typically led to the reasonable conclusion that higher levels of drinking negatively impact one's health along with the somewhat counterintuitive conclusion that low-to-moderate alcohol intake may reduce the risk of health-related consequences or confer health benefits that abstinence, notwithstanding heterogeneity of abstainer groups, does not. The J-shaped curve has been replicated in numerous large-scale epidemiological studies, systematic reviews, and meta-analyses (Di Castelnuovo et al., 2006; Krittanawong et al., 2022; Li et al., 2016). However, there is growing evidence indicating that J-shaped curves and related causal assumptions may result from systematic biases inherent to the observational data and studies from which they are derived (Zhao et al., 2023). In part, these biases may reflect methodological concerns difficult to overcome using standard approaches in epidemiological studies where inference of causal links is typically challenging. In a recent publication in Alcohol: Clinical and Experimental Research, Kember et al. (2024) conducted a retrospective, nested case–control study of the links between alcohol consumption and cardiometabolic disease (i.e., coronary heart disease [CHD] and type 2 diabetes [T2D]) in over 250,000 individuals from the Million Veteran Program (MVP; Gaziano et al., 2016). The authors used a 5:1 ratio of matched controls to cases and employed both observational and one-sample Mendelian randomization (MR) analyses to evaluate evidence of causality often assumed from J-shaped curves. A key feature of this study in the context of the broader J-shaped curve literature is the use of MR, which leverages genetic variants as instrumental variables to assess causal associations between an exposure and outcome of interest (Sanderson et al., 2022). As genotype is determined at conception, individuals are “naturally randomized” in terms of the acquisition of alleles associated with an exposure, unassociated with an outcome, and of unknown association with potential confounders. Thus, by defining their instrumental variables as genetic variation, randomly allocated from parents to offspring, that is associated with alcohol consumption but not cardiometabolic disease, MR allowed the authors to examine causal associations between these variables that are potentially free from influences of unmeasured or unobserved confounders. Leveraging electronic health record and questionnaire data from participants representing three genetic ancestry groups (African Americans, European Americans, and Hispanic Americans), Kember et al. (2024) used diagnostic codes to define CHD and T2D cases and AUDIT-C scores most proximal to first diagnosis to quantify alcohol consumption. Additionally, the authors used available data to actively control for several possible confounders, both with regard to co-occurring health traits (e.g., BMI, blood pressure, cholesterol, smoking status, and T2D for CHD and vice versa) and related genetic risk (e.g., genetic instrument variables for smoking and blood pressure). Sensitivity analyses excluded individuals who reported no alcohol consumption in the prior year to account for issues related to heterogeneity in abstainer classification (e.g., former drinkers currently abstaining vs. lifetime abstainers). Observational results in this study generally demonstrated a U-shaped association between alcohol consumption and cardiometabolic disease with low-to-moderate alcohol consumption reflecting lower odds of both CHD and T2D. However, MR analyses, conducted using both single-variant (ADH1B) and cumulative genetic score instrumental variables, revealed that this U-shaped association was unlikely to be causal. Consistent with prior MR work (van de Luitgaarden et al., 2022), these results suggest that observational associations reflecting a protective effect of low-to-moderate alcohol consumption on cardiometabolic disease may arise primarily due unmeasured confounding variables (e.g., co-morbid health conditions, lifestyle factors; Naimi et al., 2005). The study by Kember et al. (2024) has a number of strengths, and future adaptions of these features will undoubtedly improve our understanding of the relation between alcohol consumption and downstream health conditions. Chief among them is the inclusion of participant data from individuals of diverse backgrounds. Despite having much smaller overall sample sizes for African American (n ≤ 42,008) and Hispanic American (n ≤ 13,538) participants, this study is the largest MR analysis of alcohol consumption and adverse outcomes in these populations to date serving as a benchmark for future work in this area. Prior MR studies of alcohol consumption and health-related outcomes (e.g., cardiovascular disease and mortality; Biddinger et al., 2022; Kassaw et al., 2024; van de Luitgaarden et al., 2022) have yielded similar results as those reported by Kember et al. (2024) suggesting either null associations or casual, linear associations between alcohol consumption and negative health-related outcomes with no evidence for protective effects of low-to-moderate use. However, a key limitation of prior studies, necessitated primarily by data sources, is a large reliance on study participants of European ancestry who identify as white British. Lack of diversity in genetically inferred ancestral background is not unique to these studies but rather a key limitation of most extant medical genetics research (Mills & Rahal, 2019). Similar limitations are often found in the epidemiological J-shaped curve literature, which is in general hampered by nonrepresentative samples with a disproportionate representation of older white men (Stamatakis et al., 2021). Kember et al. (2024) partially address the lack of genetic diversity in the alcohol consumption-cardiometabolic disease MR literature. The initial results for individuals of African American and Hispanic American backgrounds will be important to confirm in subsequent studies both in MVP as enrollment continues to grow and in other large-scale samples with similar or greater diversity in terms of genetically inferred ancestry and self-identified race and ethnicity. Other data, particularly samples with considerable sources of diversity across a number of domains, will be invaluable in this regard. While one of the most important contributions of the study by Kember et al. (2024) is its use of an ancestrally diverse sample, all participants were U.S. veterans receiving VA care, and among other characteristics potentially unique to this population, this results in a sample that is more than 90% male. Nationally representative initiatives that reflect a broad spectrum of human diversity, such as the “All of Us” Research Program (2019), will be essential for exploring these questions further in the coming years. Other key contributions of the study by Kember et al. (2024) highlight (1) the utility of biobank-scale samples with linked electronic health records to define exposures, outcomes, and a greater number of possible confounding variables, and (2) the importance of accounting for heterogeneity among individuals reporting no alcohol use. A fundamental assumption of MR is that genetic instrumental variables influence outcomes of interest only through the exposure being studied, rather than through confounding pathways (Sanderson et al., 2022). As this assumption cannot be proved to be true, only disproved, the ability to measure and adjust for a greater number of plausible confounding variables results in more robust conclusions. In the present case, this is an important consideration as individuals endorsing low-to-moderate alcohol consumption may report greater overall health for a variety of reasons not directly related to their alcohol consumption (e.g., income, diet, and access to healthcare) that may influence observed links between alcohol consumption and cardiometabolic disease. Prior research has demonstrated that individuals reporting low-to-moderate alcohol consumption demonstrate healthier lifestyle factors as compared to abstainers and that accounting for these factors attenuates cardioprotective associations with low-to-moderate alcohol consumption (Biddinger et al., 2022). At the same time, other research suggests that associations between low-level alcohol consumption and reduced risk of cardiovascular disease may arise primarily through increased high-density lipid-cholesterol concentrations (Gaziano et al., 1999). Thus, accounting for plausible sources of confounding to the extent possible in both epidemiological and MR studies is critical for arriving at unbiased inferences about the causal links between alcohol consumption and risk of cardiometabolic disease. Individuals endorsing no alcohol consumption may abstain for a number of reasons (e.g., former drinkers currently abstaining vs. lifetime abstainers) making them a heterogeneous group. Characterizing individuals reporting abstinence as a homogenous group can bias results, and in the case of J-shaped curves, obscure the true underlying causal relation between alcohol use and health (Fillmore et al., 2007). When removing abstainers from their within-ancestry MR analyses, Kember et al. (2024) observed a small positive association between alcohol consumption and T2D in the European American sample. However, after accounting for additional measured confounders in multivariable analyses, this association was nonsignificant. More broadly, patterns and trajectories of alcohol consumption can vary widely between individuals and within the same individual across the lifespan. An important aspect of this variability with respect to identifying a causal relation between alcohol consumption and related health conditions, as noted by Kember et al. (2024) and others, is that reported abstinence at any given time may reflect different lifelong etiologies. A related limitation described by Kember et al. (2024) is that many measures used to categorize alcohol consumption are static snapshots of use during one frame of person's life, and thus, may not accurately reflect longer term patterns of alcohol consumption. Future research using longitudinal data on alcohol consumption which can separate frequency of typical consumption from frequency of heavier, episodic consumption will allow us to continue “rethinking the J-shaped curve” (Plunk et al., 2014). Finally, elevated alcohol use, and elevated use of other substances, is hypothesized to be both a consequence of and a contributing factor for many other disorders and conditions which have been linked to increased risk of physical health issues, disease status, and mortality. Notably, these include psychiatric disorders (e.g., depression and anxiety) that are currently less well-represented in this area of research despite some evidence of J-shaped curves (Visontay et al., 2023). Future studies might endeavor to similarly use MR in large-scale samples of individuals from diverse backgrounds to further our understanding of the complex and shared etiologies of both mental and physical health conditions. Kember et al. (2024) and other MR studies highlight the promise of using large-scale genetically informed analysis to support investigations of alcohol's role in the etiology of some of the world's most detrimental and chronic health issues. The nature of the connection between alcohol use and related outcomes, both positive and negative, is extremely complex. Thus, MR studies should be used in conjunction with, rather than in lieu of, traditional longitudinal and epidemiological studies to provide a more comprehensive picture of the evidence linking alcohol consumption with debilitating health conditions. On the one hand, more recent large-scale epidemiological studies have suggested that alcohol consumption may be associated with worse outcomes at all levels, resulting in a parsimonious and straightforward recommendation: “the safest level of drinking is none” (Griswold et al., 2018). On the other hand, studies like Kember et al. (2024) suggest that this association may not be causal and that other factors influencing both alcohol consumption and related health conditions (e.g., lifestyle, socioeconomic factors, and access to adequate health care) may be important avenues of future study. The exact nature of this association, particularly with respect to low-to-moderate alcohol use, is critical to disentangle as prior research has historically had substantive implications for drinking guidelines and related public health policies (Chokshi et al., 2015). Additional research is needed to reconcile conflicting conclusions, and the use of multifaceted approaches will be vital to gaining a better understanding of the relative harms, or benefits, of alcohol use. This commentary was supported in part by the National Institutes of Health Grant K01AA031724 (PI: Miller). National Institute on Alcohol Abuse and Alcoholism, Grant/Award Number: K01AA031724. The author declares that there are no conflicts of interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study.
No takes yet. Share an insight, caveat, or question.
Alex P. Miller (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: